# Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers

> **NCT02931214** · PHASE1 · COMPLETED · sponsor: **GlycoMimetics Incorporated** · enrollment: 58 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GMI-1359
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02931214
- **Lead sponsor:** GlycoMimetics Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-10
- **Final completion:** 2018-11
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931214, "Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02931214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*